Magnera Corp

Magnera reported third fiscal quarter revenue/net sales of $857 million and adjusted EBITDA of $99 million. Earnings grew 9% year over year, with a 70 basis point improvement versus the prior-year quarter. Organic sales growth was 1%, Americas revenue was essentially flat, Americas adjusted EBITDA increased 16% to $71 million, and Rest of World revenue increased modestly while adjusted EBITDA declined slightly year over year. Management reaffirmed full-year free cash flow guidance of approximately $90 million to $110 million, but said adjusted EBITDA is now expected to finish toward the lower end of the previously communicated range. They also said about $575 million of available liquidity was on hand at quarter end.

Curt Begle framed the quarter as proof that the merger integration and transformation work are translating into results, calling it Magnera’s strongest earnings quarter since creation. He emphasized disciplined execution, synergy delivery, Project CORE, and a portfolio focused on mission-critical, non-discretionary categories such as wipes, filtration, and personal care. He also highlighted the Universa wipes launch and said the company is pushing toward higher-value, differentiated products with stronger customer collaboration and better mix.

Jim Till said results were generally in line with expectations and that this was the first quarter with the full run-rate benefits from Project CORE and merger synergies. He noted raw material inflation accelerated during the quarter, but pricing actions substantially offset the pressure, with some timing lag in Rest of World expected to flow through in Q4. He reaffirmed free cash flow guidance of approximately $90 million to $110 million, said the company ended with about $575 million of available liquidity, and pointed to lower expected CapEx of roughly $60 million versus an earlier guide of about $80 million as an offset to lower EBITDA outlook.

Analysts focused on short-term demand trends, pricing lag, the gap between the previously discussed pro forma EBITDA target and current expectations, and how free cash flow will be achieved. Management said order patterns were steady and Q4 demand looked similar to Q3, while a couple million dollars of pricing lag in Rest of World should flow through in the fourth quarter. On EBITDA trajectory, Jim Till reiterated that around $20 million of run-rate synergies and CORE benefits are still expected to carry into 2027, and on cash flow he said CapEx should help offset EBITDA pressure while working capital improvement remains a key fourth-quarter task.